Most Read News

Gokul Refoils and Solvent Limited has informed the Exchange about Board Meeting held on 08-Aug-2022 to consider financial statements for the period ended June 2022

Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation

AstraZeneca Pharma India Limited has informed the Exchange about Board Meeting held on 08-Aug-2022 to consider financial statements for the period ended June 2022

Further to our letter of date intimating the Financial Results of the Company for the quarter ended June 30, 2022, enclosed is a copy of the Press Release on the same for your records.

Dhunseri Ventures Limited has informed the Exchange about Proceedings of Annual General Meeting held on 08-Aug-2022

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 08-Aug-2022 titled Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%

Please find enclosed herewith Statement of Unaudited Financial Results (Standalone) for the quarter ended June 30, 2022, duly approved and taken on record by the Board of Directors of the Company at their meeting held today i.e. on August 8, 2022. The ???Limited Review Report??? issued by P G Bhagwat LLP, Chartered Accountants, Pune, Auditors of the Company, with respect to the said results is also enclosed.

The Anup Engineering Limited has informed the Exchange about Investor Presentation

Sun Pharma Advanced Research Company Limited has informed the Exchange about Board Meeting held on 08-Aug-2022 to consider financial statements for the period ended June 2022 and Fund raising

Summit Securities Limited has informed the Exchange about Board Meeting held on 08-Aug-2022 to consider financial statements for the period ended June 2022